Arcutis Biotherapeutics, Inc.
ARQT
21 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 11:43 PM | Latha VairavanSVP Chief Financial Officer | Sale | 435 | $21.05 | $9.2K | 85,978(D) | View → |
| May 11, 2026 | May 13 11:42 PM | Patrick BurnettReporting Person's Title: EVP, Chief Medical Officer | Sale | 222 | $21.05 | $4.7K | 120,244(D) | View → |
| May 11, 2026 | May 11 8:44 PM | Patrick Burnett | Proposed Sale | 222 | $21.05 | $4.7K | — | View → |
| May 11, 2026 | May 11 8:35 PM | Latha Vairavan | Proposed Sale | 435 | $21.05 | $9.2K | — | View → |
| May 4, 2026 | May 6 11:40 PM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Sale | 8,256 | $23.31 | $192.4K | 126,689(D) | View → |
| May 4, 2026 | May 6 10:15 PM | Patrick BurnettReporting Person's Title: EVP, Chief Medical Officer | Sale | 684 | $23.61 | $16.1K | 120,466(D) | View → |
| May 4, 2026 | May 6 10:13 PM | Latha VairavanSVP Chief Financial Officer | Sale | 1,341 | $23.61 | $31.7K | 86,413(D) | View → |
| May 4, 2026 | May 6 10:06 PM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Sale | 3,172 | $23.61 | $74.9K | 720,755(D) | View → |
| May 1, 2026 | May 6 12:21 AM | Howard G. WelgusDirector | Sale | 7,144 | $22.99 | $164.2K | 32,600(D) | View → |
| May 4, 2026 | May 4 9:19 PM | Patrick Burnett | Proposed Sale | 684 | $23.61 | $16.1K | — | View → |
| May 4, 2026 | May 4 9:18 PM | Latha Vairavan | Proposed Sale | 1,341 | $23.61 | $31.7K | — | View → |
| May 4, 2026 | May 4 9:18 PM | Todd Watanabe | Proposed Sale | 3,172 | $23.61 | $74.9K | — | View → |
| May 4, 2026 | May 4 9:05 PM | Masaru Matsuda | Proposed Sale | 8,256 | $23.31 | $192.4K | — | View → |
| May 1, 2026 | May 1 8:04 PM | Howard Welgus | Proposed Sale | 7,144 | $22.99 | $164.2K | — | View → |
| Apr 1, 2026 | Apr 3 9:46 PM | Howard G. WelgusDirector | Sale | 10,000 | $23.88 | $238.8K | 39,744(D) | View → |
| Apr 1, 2026 | Apr 1 8:02 PM | Howard Welgus | Proposed Sale | 10,000 | $23.88 | $238.8K | — | View → |
| Mar 2, 2026 | Mar 4 9:17 PM | Keith R LeonardDirector | Sale | 39,272 | $25.39 | $997.2K | 22,123(D) | View → |
| Mar 2, 2026 | Mar 4 9:16 PM | Howard G. WelgusDirector | Sale | 10,000 | $25.65 | $256.5K | 49,744(D) | View → |
| Mar 2, 2026 | Mar 4 1:43 AM | Larry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer | Sale | 3,687 | $25.18 | $92.8K | 175,178(D) | View → |
| Mar 2, 2026 | Mar 4 1:42 AM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Sale | 37,349 | $25.18 | $940.5K | 785,957(D) | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 9:17 PM | Keith R LeonardDirector | Option Exercise | 39,272 | $8.63 | 0(D) | View → |
| Feb 27, 2026 | Mar 4 1:43 AM | Larry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Grant/Award | 266,000 | $26.97 | 266,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Grant/Award | 97,000 | $26.97 | 97,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Latha VairavanSVP Chief Financial Officer | Grant/Award | 70,000 | $26.97 | 70,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:41 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |